Search Results - "Siminski, S"

Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium by King, L, Hayashi, K, Genberg, B, Choi, J, DeBeck, K, Kirk, G, Mehta, S H, Kipke, M, Moore, R D, Baum, M K, Shoptaw, S, Gorbach, P M, Mustanski, B, Javanbakht, M, Siminski, S, Milloy, M-J

“…Data from the COVID-19 pandemic describes increases in drug use and related harms, especially fatal overdose. However, evidence is needed to better understand…”
Get full text

Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research by DiFrancesco, R, Tooley, K, Rosenkranz, S L, Siminski, S, Taylor, C R, Pande, P, Morse, G D

“…The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical…”
Get full text

Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates by Mirochnick, Mark, Fenton, Terry, Gagnier, Paul, Pav, Joseph, Gwynne, Meg, Siminski, Sue, Sperling, Rhoda S., Beckerman, Karen, Jimenez, Eleanor, Yogev, Ram, Spector, Stephen A., Sullivan, John L.

“…The safety, toxicity, and pharmacokinetics of intrapartum and early newborn nevirapine were evaluated in 17 human immunodeficiency virus type 1-infected women…”
Get full text

NEVIRAPINE PHARMACOKINETICS IN PREGNANT WOMEN AND IN THEIR INFANTS AFTER IN UTERO EXPOSURE by Mirochnick, Mark, Siminski, Sue, Fenton, Terry, Lugo, Miladi, Sullivan, John L

“…The safety, toxicity and pharmacokinetics of nevirapine were studied in HIV-infected pregnant women beginning chronic therapy late in the third trimester and…”
Get full text

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team by Mirochnick, M, Fenton, T, Gagnier, P, Pav, J, Gwynne, M, Siminski, S, Sperling, R S, Beckerman, K, Jimenez, E, Yogev, R, Spector, S A, Sullivan, J L

“…The safety, toxicity, and pharmacokinetics of intrapartum and early newborn nevirapine were evaluated in 17 human immunodeficiency virus type 1-infected women…”
Get full text

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team by Starr, S E, Fletcher, C V, Spector, S A, Yong, F H, Fenton, T, Brundage, R C, Manion, D, Ruiz, N, Gersten, M, Becker, M, McNamara, J, Mofenson, L M, Purdue, L, Siminski, S, Graham, B, Kornhauser, D M, Fiske, W, Vincent, C, Lischner, H W, Dankner, W M, Flynn, P M

“…Consistent long-term viral suppression has been difficult to achieve in children with human immunodeficiency virus type 1 (HIV-1) infection. We tested the…”
Get full text

A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128 by Haas, David W, Wilkinson, Grant R, Kuritzkes, Daniel R, Richman, Douglas D, Nicotera, Janet, Mahon, Laura F, Sutcliffe, Cara, Siminski, Sue, Andersen, Janet, Coughlin, Kristine, Clayton, Ellen W, Haines, Jonathan, Marshak, Ann, Saag, Michael, Lawrence, Jody, Gustavson, Jeffrey, Anne Bennett, Jo, Christensen, Rolf, Matula, Margaret A, Wood, Alastair J J

“…An understanding of the relationships among allelic variability and clinical outcomes will be critical if HIV-infected patients are to benefit from the…”
Get more information

Long-term pulmonary complications in perinatally HIV-infected youth by Shearer, William T., MD, PhD, Jacobson, Denise L., PhD, MPH, Yu, Wendy, MPH, Siberry, George K., MD, MPH, Purswani, Murli, MD, Siminski, Suzanne, MS, MBA, Butler, Laurie, MBA, MT, Leister, Erin, MS, Scott, Gwendolyn, MD, Van Dyke, Russell B., MD, Yogev, Ram, MD, Paul, Mary E., MD, Puga, Ana, MD, Colin, Andrew A., MD, Kattan, Meyer, MD

“…Background Increased incidence and prevalence of asthma have been documented for perinatally HIV-infected youth 10 to 21 years of age compared with HIV-exposed…”
Get full text